Name: Signs, Symptoms, and Risk Factors for CMV
Uploaded: 2022-07-08T14:30:04.085Z
Description: Allison August, MD, Kathleen Muldoon, PhD, Stanley Plotkin, MD, and Patricia Purcell, MD, MPH, share recommendations for messaging that healthcare providers should be sharing regarding CMV.

Breast Health

COVID-19

Cervical Health 

Contraception

Curbside Consults

Dermatology

Drug Pipeline News

Endometriosis

Genetic Testing

Gynecologic Oncology

Gynecology

Fetal Imaging

Abnormal Obstetrical Ultrasound

Ultrasound

Women's Imaging

Breast Imaging

Women's Ultrasound

Imaging

Infertility

LARC

Legally Speaking

Life Transitions

Malpractice

Menopause

Mental Health

Noninvasive Prenatal Testing

Obstetrics

Opinion

Osteoporosis

Pediatrics

Practice Management

Pregnancy and Birth

Sexual Health

Sexually Transmitted Infections

Surgery

Technology

Urology

Uterine Fibroids

Vulvovaginal Disease

Well Woman

About

News

Media

Podcasts

Insights

Medical World News

Peer Exchange

Peers & Perspectives

Videos

Conferences

Conference Coverage

Conference Listing

Publications

Contemporary OB/GYN® Journal

Digital Supplements

CME/CE

Resources

Physician Fact Sheets

Interactive Tools

Supplements and Featured Publications

Subscribe

Editorial Board

Partnerships

Articles

Explore the latest Commonwealth Fund report revealing persistent racial inequities in health care access and outcomes, prompting urgent calls for targeted policy interventions and systemic reform.

Commonwealth Fund 2024 report unravels US racial and ethnic disparities

Recent research evaluated the impact of maternal hyperoxygenation on neonatal Apgar scores, revealing no significant enhancement in outcomes among women with pathologic fetal heart rate tracing and suggesting limited efficacy of hyperoxygenation therapy in this context.

Hyperoxygenation use not linked to neonatal outcomes

A recent study revealed that patients with untreated or new-onset hypertension face elevated chances of uterine fibroid diagnosis, underscoring the potential of antihypertensive therapy in mitigating this risk among midlife individuals.

Study finds antihypertensive treatment reduces uterine fibroids risk

A recent study explored the correlation between placental histologic types and recurrent preterm birth risk, shedding light on potential predictive factors for obstetric outcomes.

Understanding histologic patterns in spontaneous preterm birth recurrence

Advertise

Contact Us

Job Board

Terms of Use

Privacy Policy

Do Not Sell My Personal Information

Contemporary OB/GYN

Twitter

Facebook

LinkedIn

RSS Feed

Spotlight

CMV: In the Know

RSV Roundtable

STIs

Supplement: Closing the Gap in Cervical Cancer Screening

Vaginismus: Managing a Misunderstood and Underdiagnosed Condition

Why vNOTES Make Sense for My Patients

1rem

View

In this educational roundtable, a multidisciplinary panel of experts explores symptoms and risk factors of CMV and highlights the unmet needs around screening and prevention.

Allison August, MD, Kathleen Muldoon, PhD, Stanley Plotkin, MD, and Patricia Purcell, MD, MPH, share recommendations for messaging that healthcare providers should be sharing regarding CMV.

Overview and Prevalence of CMV

Signs, Symptoms, and Risk Factors for CMV

Allison August, MD, Kathleen Muldoon, PhD, Stanley Plotkin, MD, and Patricia Purcell, MD, MPH, explore key strategies and takeaways that healthcare providers can use to discuss transmission of CMV with their patients.

CMV Transmission

Thought leaders discuss the low rates of screening for CMV and what healthcare providers can do to boost prevention efforts.

CMV Screening and Prevention

Allison August, MD, Kathleen Muldoon, PhD, Stanley Plotkin, MD, and Patricia Purcell, MD, MPH, reveal tips regarding the most important points to emphasize when talking to patients about CMV.

The Importance of the HCP-patient CMV Conversation

Experts discuss the trajectory of CMV awareness and vaccine development efforts.

Historical Difficulty in Safely and Effectively Preventing CMV

Signs, Symptoms, and Risk Factors for CMV

EP: 1.Overview and Prevalence of CMV

EP: 2.Signs, Symptoms, and Risk Factors for CMV

EP: 3.CMV Transmission

EP: 4.CMV Screening and Prevention

EP: 5.The Importance of the HCP-patient CMV Conversation

EP: 6.Historical Difficulty in Safely and Effectively Preventing CMV